|
|
|
|
In this teleconference, bio-era experts and guest commentators addressed the implications of ongoing advances in enabling biotechnologies as they affect stakeholders in the agriculture and food systems. Participating on this call were individuals from government and multilateral institutions including the USDA and EPA, the U.S. House and Senate, Agriculture and Agrifood Canada, the European Union, the French Embassy, and the World Bank. Industry participants included representatives from major bio-chemical and agricultural companies, the Grocery Manufacturers Association, and other niche players providing information services to support the ongoing evolution of agriculture and agricultural biotechnology. This call was the second in a series of interactive conference calls following the release of Part I of the bio-era report series Agricultural Biotechnology at the Crossroads: The Changing Structure of the Industry.
- What are the new and enabling biotechnologies that matter most?
- How are they affecting the pace of change?
- How might these technologies shift the competitive playing field and open up new opportunities for smaller players?
- What are the non-technological constraints to progress?
- What are the implications for other stakeholders?
- Agricultural biotechnology executives
- Venture capital firms and others investing in the agricultural biotechnology arena
- Universities and other public-sector research programs involved in agricultural biotechnology
- Federal, state and international agencies involved in legislating, regulating and enforcing regulations surrounding enabling biotechnologies
Stephen Aldrich, President and CEO, bio-era Alan Bennett, PhD, Executive Director, University of California System-Wide Office of Technology Transfer and Research Administration; Professor, College of Agricultural & Environmental Sciences, University of California at Davis Gregory Graff, PhD, Director of Research, bio-era Roger Wyse, PhD, Managing Director, Burrill & Company
At universities, sponsored research and technology transfer has slowed in agbiotech relative to other areas, according to Alan Bennett of the University of California, because smaller companies often do not have affordable access to complementary technologies required for freedom to operate...
As competition shifts down stream from research tools and general methods, to competition in specific product markets, higher value output products are likely to become more important in the industry. The future is likely to bring...
Click here to apply for a bio-era membership and to participate.
top
|
|
